Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation

被引:28
作者
Cristillo, Anthony D. [1 ]
Weiss, Deborah [1 ]
Hudacik, Lauren [1 ]
Restrepo, Susana [1 ]
Galmin, Lindsey [1 ]
Suschak, John [1 ]
Draghia-Akli, Ruxandra [2 ]
Markham, Phillip [1 ]
Pal, Ranajit [1 ]
机构
[1] Adv BioSci Labs Inc, Dept Cell Biol, Kensington, MD 20895 USA
[2] VGX Pharmaceut, Immune Therapeut Div, The Woodlands, TX 77381 USA
关键词
HIV-1; vaccine; electroporation; cellular immunity; humoral immunity; DNA vaccines;
D O I
10.1016/j.bbrc.2007.11.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intramuscular needle injection of HIV-1 DNA vaccines typically elicits weak immune responses in immunized individuals. To improve such responses, the immunogenicity of a vaccine consisting of electroporated DNA followed by intramuscular protein boost was evaluated in rabbits and macaques. In macaques, electroporation of low dose DNA encoding HIV-1 env followed by gp 120 protein elicited Th1 cytokines and functional CTL that persisted for over I year. In both macaques and rabbits, robust anti-envelope antibodies, elicited by electroporated DNA, were augmented by gp120 protein and such responses neutralized sensitive SHIV isolates. These findings highlight efficient priming of immune responses by electroporated DNA that in conjunction with protein boost may give rise to long-term immunity in immunized hosts. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 24 条
[1]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[2]   Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine [J].
Cristillo, AD ;
Wang, SX ;
Caskey, MS ;
Unangst, T ;
Hocker, L ;
He, LL ;
Hudacik, L ;
Whitney, S ;
Keen, T ;
Chou, THW ;
Shen, SY ;
Joshi, S ;
Kalyanaraman, VS ;
Nair, B ;
Markham, P ;
Lu, S ;
Pal, R .
VIROLOGY, 2006, 346 (01) :151-168
[3]   HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3 [J].
Cristillo, Anthony D. ;
Lisziewicz, Julianna ;
He, Leilei ;
Lori, Franco ;
Galmin, Lindsey ;
Trocio, Jeffrey N. ;
Unangst, Tami ;
Whitman, Lucia ;
Hudacik, Lauren ;
Bakare, Nyasha ;
Whitney, Stephen ;
Restrepo, Susana ;
Suschak, John ;
Ferrari, Maria Grazi ;
Chung, H. K. ;
Kalyanaraman, Vaniambadi S. ;
Markham, Phillip ;
Pal, Ranajit .
VIROLOGY, 2007, 366 (01) :197-211
[4]   The rational design of an AIDS vaccine [J].
Douek, DC ;
Kwong, PD ;
Nabell-, GJ .
CELL, 2006, 124 (04) :677-681
[5]   Plasmid-based expression technology using growth hormone releasing hormone: A novel method for physiologically stimulating long-term growth hormone secretion [J].
Draghia-Akli, R ;
Pope, MA ;
Brown, PA ;
Khan, AS .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2006, 9 (03) :181-185
[6]   Highly efficient constant-current electroporation increases in vivo plasmid expression [J].
Khan, AS ;
Pope, MA ;
Draghia-Akli, R .
DNA AND CELL BIOLOGY, 2005, 24 (12) :810-818
[7]   Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy [J].
Law, Mansun ;
Cardoso, Rosa M. F. ;
Wilson, Ian A. ;
Burton, Dennis R. .
JOURNAL OF VIROLOGY, 2007, 81 (08) :4272-4285
[8]   Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost [J].
Liu, Jinyan ;
Hellerstein, Michael ;
McDonnel, Michael ;
Amara, Rama Rao ;
Wyatt, Linda S. ;
Moss, Bernard ;
Robinson, Harriet L. .
VACCINE, 2007, 25 (15) :2951-2958
[9]  
LUCKAY A, 2007, J VIROL
[10]   Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines [J].
Montefiori, DC ;
Metch, B ;
McElrath, MJ ;
Self, S ;
Weinhold, KJ ;
Corey, L .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (11) :1962-1969